About nephros inc - NEPH
Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company operates in two segments: Water Filtration, Pathogen Detection and Renal Products. The Water Filtration segment includes both the medical device and commercial filtration product lines. The Pathogen Detection segment develops and sells portable, real-time water testing systems designed to provide actionable data on waterborne pathogens in approximately one hour. The Renal Products segment consists of SRP, which is focused on the development of medical device products for patients with renal disease, including a second-generation HDF system for the treatment of patients with ESRD. Its ultrafilters are used in dialysis centers for the removal of biological contaminants from water, bicarbonate concentrate, and blood. The company was founded on April 3, 1997 and is headquartered in South Orange, NJ.
NEPH At a Glance
Nephros, Inc.
380 Lackawanna Place
South Orange, New Jersey 07079
| Phone | 1-201-343-5202 | Revenue | 18.79M | |
| Industry | Medical Specialties | Net Income | 1.19M | |
| Sector | Health Technology | 2025 Sales Growth | 32.672% | |
| Fiscal Year-end | 12 / 2026 | Employees | 36 | |
| View SEC Filings |
NEPH Valuation
| P/E Current | 25.942 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 44.812 |
| Price to Sales Ratio | 2.849 |
| Price to Book Ratio | 5.092 |
| Price to Cash Flow Ratio | 32.54 |
| Enterprise Value to EBITDA | 38.248 |
| Enterprise Value to Sales | 2.618 |
| Total Debt to Enterprise Value | 0.022 |
NEPH Efficiency
| Revenue/Employee | 521,916.667 |
| Income Per Employee | 33,166.667 |
| Receivables Turnover | 7.783 |
| Total Asset Turnover | 1.512 |
NEPH Liquidity
| Current Ratio | 4.056 |
| Quick Ratio | 2.888 |
| Cash Ratio | 1.952 |
NEPH Profitability
| Gross Margin | 61.126 |
| Operating Margin | 6.099 |
| Pretax Margin | 6.419 |
| Net Margin | 6.355 |
| Return on Assets | 9.609 |
| Return on Equity | 12.711 |
| Return on Total Capital | 10.599 |
| Return on Invested Capital | 11.636 |
NEPH Capital Structure
| Total Debt to Total Equity | 10.42 |
| Total Debt to Total Capital | 9.436 |
| Total Debt to Total Assets | 7.793 |
| Long-Term Debt to Equity | 6.587 |
| Long-Term Debt to Total Capital | 5.965 |